Technology
Health
Biotechnology

Blueprint Medicines

$84.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.73 (2.09%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell BPMC and other stocks, options, ETFs, and crypto commission-free!

About

Blueprint Medicines Corporation Common Stock, also called Blueprint Medicines, is a precision therapy company, which focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Read More Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.

Employees
217
Headquarters
Cambridge, Massachusetts
Founded
2008
Market Cap
3.74B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
416.87K
High Today
$85.45
Low Today
$82.47
Open Price
$83.50
Volume
203.46K
52 Week High
$89.00
52 Week Low
$44.58

Collections

Technology
Health
Biotechnology
Therapy
Cancer Prevention
2015 IPO
US
North America

News

Yahoo FinanceMay 10

Edited Transcript of BPMC earnings conference call or presentation 9-May-19 12:30pm GMT

Q1 2019 Blueprint Medicines Corp Earnings Call CAMBRIDGE May 10, 2019 (Thomson StreetEvents) -- Edited Transcript of Blueprint Medicines Corp earnings conference call or presentation Thursday, May 9, 2019 at 12:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Anthony L. Boral Blueprint Medicines Corporation - Chief Medical Off...

45
Yahoo FinanceApr 30

See what the IHS Markit Score report has to say about Blueprint Medicines Corp.

Blueprint Medicines Corp NASDAQ/NGS:BPMC View full report here! Summary Bearish sentiment is low Economic output in this company's sector is expanding Bearish sentiment Short interest | Positive Short interest is low for BPMC with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flow ETF/Index ownership | Neutral ...

83
Yahoo FinanceApr 29

Did Hedge Funds Drop The Ball On Blueprint Medicines Corporation (BPMC) ?

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors.

74

Earnings

-$1.98
-$1.53
-$1.07
-$0.62
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 31, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.